12/08/22 -"Declining effects from pandemic improved 1H22 earnings but still well below pre-pandemic levels – AGM on 30 August with DPS of EUR 1.00"
12/08/22 -"Declining effects from pandemic improved 1H22 earnings but still well below pre-pandemic levels – AGM on 30 August with DPS of EUR 1.00"
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
Corporate broking | NO |
Trading in corporate shares | NO |
Analyst ownership | NO |
Advising of corporate (strategy, marketing, debt, etc) | NO |
Research paid for by corporate | NO |
Provision of corporate access paid for by corporate | NO |
Link between and a banking entity | NO |
Brokerage activity at AlphaValue | NO |